Following migration of APCs to draining lymph nodes and the successful cross-presentation of antigens, activation of anti-tumour immune responses secondary to OAd oncolysis can ensue, particularly by CD8+ T cells (Nattress and Halldén, 2018). This evidence concerns the gene CD8A and neoplasm.